Alan J Kivitz MD

Clinical Trials

• A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis Start of enrollment: 2005 Dec 01

  Terminated

  Phase 2

• Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee Start of enrollment: 2006 Apr 01

  Completed

  Not Applicable

• Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome Start of enrollment: 2008 Feb 01

  Completed

  Phase 2

• Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers Start of enrollment: 2009 Jan 01

  Completed

  Phase 1, Phase 2

• Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee Start of enrollment: 2006 Mar 01

  Completed

  Not Applicable

• Safety and Efficacy Study of Intravenous Uricase-PEG 20 Start of enrollment: 2009 Oct 01

  Unknown status

  Phase 1

• Safety and Efficacy Study of Intramuscular Uricase-PEG 20 Start of enrollment: 2009 Dec 01

  Unknown status

  Phase 1

• A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome Start of enrollment: 2011 Mar 01

  Completed

  Phase 3

• Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects Start of enrollment: 2013 May 01

  Completed

  Phase 1

• Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis

  COMPLETED

  PHASE4

• Study of Meloxicam Capsules to Treat Osteoarthritis Pain Start of enrollment: 2013 Feb 01

  Completed

  Phase 3

• Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE. Start of enrollment: 2013 Jul 01

  Completed

  Phase 1, Phase 2

• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27

  Completed

  Phase 3

• A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01

  Terminated

  Phase 3

• A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Start of enrollment: 2014 Feb 01

  Completed

  Phase 2

• Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) Start of enrollment: 2014 May 01

  Completed

  Phase 3

• Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16

  Completed

  Phase 3

• A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain Start of enrollment: 2014 Jul 01

  Terminated

  Phase 2

• A Study of LY3337641 in Rheumatoid Arthritis Start of enrollment: 2016 Aug 22

  Terminated

  Phase 2

• Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon Start of enrollment: 2016 Feb 01

  Completed

  Not Applicable

• A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 12

  Completed

  Phase 3

• A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09

  Completed

  Phase 3

• Join now to see all